Inhibition of SF3b1 by pladienolide B evokes cycle arrest, apoptosis induction and p73 splicing in human cervical carcinoma cells

References

• Fitzmaurice C, Allen C, Barber RM, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol. 2017;3:524–548.
   PubMed Web of Science ®Google Scholar
• Chen Z, Zhang M, Qiao Y, et al. MicroRNA-1297 contributes to the progression of human cervical carcinoma through PTEN. Artif Cells Nanomed Biotechnol. 2018;46(sup 2):1120–1126.
   Web of Science ®Google Scholar
• Javadi H, Lotfi AS, Hosseinkhani S, et al. The combinational effect of E6/E7 siRNA and anti-miR-182 on apoptosis induction in HPV16-positive cervical cells. Artif Cells Nanomed Biotechnol. 2018;46(sup2):727–736.
   Web of Science ®Google Scholar
• Cong J, Liu R, Wang X, et al. MiR-634 decreases cell proliferation and induces apoptosis by targeting mTOR signaling pathway in cervical cancer cells. Artif Cells Nanomed Biotechnol. 2016;44:1694–1701.
   PubMed Web of Science ®Google Scholar
• Dutertre M, Vagner S, Auboeuf D. Alternative splicing and breast cancer. RNA Biol. 2010;7:403–411.
   PubMed Web of Science ®Google Scholar
• Urbanski LM, Leclair N, Anczukow O. Alternative-splicing defects in cancer: splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics. Wiley Interdiscip Rev RNA. 2018;9:e1476.
   PubMed Web of Science ®Google Scholar
• Neelamraju Y, Gonzalez-Perez A, Bhat-Nakshatri P, et al. Mutational landscape of RNA-binding proteins in human cancers. RNA Biol. 2018;15:115–129.
   PubMed Web of Science ®Google Scholar
• Paschalis A, Sharp A, Welti JC, et al. Alternative splicing in prostate cancer. Nat Rev Clin Oncol. 2018;15:663–675.
   PubMed Web of Science ®Google Scholar
• Kumar N, Chugh H, Tomar R, et al. Exploring the interplay between autoimmunity and cancer to find the target therapeutic hotspots. Artif Cells Nanomed Biotechnol. 2018;46:658–668.
   PubMed Web of Science ®Google Scholar
• Wang ET, Sandberg R, Luo S, et al. Alternative isoform regulation in human tissue transcriptomes. Nature. 2008;456:470–476.
   PubMed Web of Science ®Google Scholar
• De Conti L, Baralle M, Buratti E. Exon and intron definition in pre-mRNA splicing. Wiley Interdiscip Rev RNA. 2013;4:49–60.
   PubMed Web of Science ®Google Scholar
• Bonnal S, Vigevani L, Valcarcel J. The spliceosome as a target of novel antitumour drugs. Nat Rev Drug Discov. 2012;11:847–859.
   PubMed Web of Science ®Google Scholar
• Matera AG, Wang Z. A day in the life of the spliceosome. Nat Rev Mol Cell Biol. 2014;15:108–121.
   PubMed Web of Science ®Google Scholar
• Vosseberg J, Snel B. Domestication of self-splicing introns during eukaryogenesis: the rise of the complex spliceosomal machinery. Biol Direct. 2017;12:30.
   PubMed Web of Science ®Google Scholar
• Blencowe BJ. The relationship between alternative splicing and proteomic complexity. Trends Biochem Sci. 2017;42:407–408.
   PubMed Web of Science ®Google Scholar
• van Alphen RJ, Wiemer EA, Burger H, et al. The spliceosome as target for anticancer treatment. Br J Cancer. 2009;100:228–232.
   PubMed Web of Science ®Google Scholar
• Effenberger KA, Urabe VK, Prichard BE, et al. Interchangeable SF3B1 inhibitors interfere with pre-mRNA splicing at multiple stages. RNA. 2016;22:350–359.
   PubMed Web of Science ®Google Scholar
• Kim Guisbert KS, Guisbert E. SF3B1 is a stress-sensitive splicing factor that regulates both HSF1 concentration and activity. PLoS One. 2017;12:e0176382.
   PubMed Web of Science ®Google Scholar
• Scotti MM, Swanson MS. RNA mis-splicing in disease. Nat Rev Genet. 2016;17:19–32.
   PubMed Web of Science ®Google Scholar
• Yokoi A, Kotake Y, Takahashi K, et al. Biological validation that SF3b is a target of the antitumor macrolide pladienolide. FEBS J. 2011;278:4870–4880.
   PubMed Web of Science ®Google Scholar
• Wu G, Fan L, Edmondson MN, et al. Inhibition of SF3B1 by molecules targeting the spliceosome results in massive aberrant exon skipping. RNA. 2018;24:1056–1066.
   PubMed Web of Science ®Google Scholar
• Sato M, Muguruma N, Nakagawa T, et al. High antitumor activity of pladienolide B and its derivative in gastric cancer. Cancer Sci. 2014;105:110–116.
   PubMed Web of Science ®Google Scholar
• Effenberger KA, Anderson DD, Bray WM, et al. Coherence between cellular responses and in vitro splicing inhibition for the anti-tumor drug pladienolide B and its analogs. J Biol Chem. 2014;289:1938–1947.
   PubMed Web of Science ®Google Scholar
• Wu G, Fan L, Edmonson MN, et al. Inhibition of SF3B1 by molecules targeting the spliceosome results in massive aberrant exon skipping. RNA. 2018;24:1056–1066.
   PubMed Web of Science ®Google Scholar
• Mizui Y, Sakai T, Iwata M, et al. Pladienolides, new substances from culture of Streptomyces platensis Mer-11107. III. In vitro and in vivo antitumor activities. J Antibiot. 2004;57:188–196.
   PubMed Web of Science ®Google Scholar
• Kotake Y, Sagane K, Owa T, et al. Splicing factor SF3b as a target of the antitumor natural product pladienolide. Nat Chem Biol. 2007;3:570–575.
   PubMed Web of Science ®Google Scholar
• Maciejewski JP, Padgett RA. Defects in spliceosomal machinery: a new pathway of leukaemogenesis. Br J Haematol. 2012;158:165–173.
   PubMed Web of Science ®Google Scholar
• Khan I, Bahuguna A, Bhardwaj M, et al. Carvacrol nanoemulsion evokes cell cycle arrest, apoptosis induction and autophagy inhibition in doxorubicin resistant-A549 cell line. Artif Cells Nanomed Biotechnol. 2018;46(sup 1):664–675.
   Web of Science ®Google Scholar
• Di CX, Han L, Zhang H, et al. Diallyl disulfide attenuated carbon ion irradiation-induced apoptosis in mouse testis through changing the ratio of Tap73/ΔNp73 via mitochondrial pathway. Sci Rep. 2015;5:16020.
   PubMed Web of Science ®Google Scholar
• Di C, Sun C, Li H, et al. Diallyl disulfide enhances carbon ion beams-induced apoptotic cell death in cervical cancer cells through regulating Tap73/DeltaNp73. Cell Cycle. 2015;14:3725–3733.
   PubMed Web of Science ®Google Scholar
• Di C, Yang L, Zhang H, et al. Mechanisms, function and clinical applications of DNp73. Cell Cycle. 2013;12:1861–1867.
   PubMed Web of Science ®Google Scholar
• Kalsotra A, Cooper TA. Functional consequences of developmentally regulated alternative splicing. Nat Rev Genet. 2011;12:715–729.
   PubMed Web of Science ®Google Scholar
• Xargay-Torrent S, Lopez-Guerra M, Rosich L, et al. The splicing modulator sudemycin induces a specific antitumor response and cooperates with ibrutinib in chronic lymphocytic leukemia. Oncotarget. 2015;6:22734–22749.
   PubMed Web of Science ®Google Scholar
• Kramer A. The structure and function of proteins involved in mammalian pre-mRNA splicing. Annu Rev Biochem. 1996;65:367–409.
   PubMed Web of Science ®Google Scholar
• Aouida M, Eid A, Mahfouz MM. CRISPR/Cas9-mediated target validation of the splicing inhibitor Pladienolide B. Biochim Open. 2016;3:72–75.
   PubMedGoogle Scholar
• Zhang J, Du J, Liu Q, et al. Down-regulation of STAT3 expression using vector-based RNA interference promotes apoptosis in Hepatocarcinoma cells. Artif Cells Nanomed Biotechnol. 2016;44:1201–1205.
   PubMed Web of Science ®Google Scholar
• Huang Y, Hale J, Wang Y, et al. SF3B1 deficiency impairs human erythropoiesis via activation of p53 pathway: implications for understanding of ineffective erythropoiesis in MDS. J Hematol Oncol. 2018;11:19.
   PubMed Web of Science ®Google Scholar
• Goh AM, Lane DP. How p53 wields the scales of fate: arrest or death?. Transcription. 2012;3:240–244.
   PubMedGoogle Scholar
• Jost CA, Marin MC, Kaelin WG. Jr., p73 is a simian [correction of human] p53-related protein that can induce apoptosis. Nature. 1997;389:191–194.
   PubMed Web of Science ®Google Scholar
• Muller M, Schilling T, Sayan AE, et al. TAp73/Delta Np73 influences apoptotic response, chemosensitivity and prognosis in hepatocellular carcinoma. Cell Death Differ. 2005;12:1564–1577.
   PubMed Web of Science ®Google Scholar
• Lucena-Araujo AR, Kim HT, Thome C, et al. High ΔNp73/TAp73 ratio is associated with poor prognosis in acute promyelocytic leukemia. Blood. 2015;126:2302–2306.
   PubMed Web of Science ®Google Scholar
• Sadat Shandiz SA, Shafiee Ardestani M, Shahbazzadeh D, et al. Novel imatinib-loaded silver nanoparticles for enhanced apoptosis of human breast cancer MCF-7 cells. Artif Cells Nanomed Biotechnol. 2017;45(6):1–10.
   PubMed Web of Science ®Google Scholar